TP53 and cancer: The KEGG and GO enrichment of pathways such as the cell cycle, p53 signaling pathway, apoptosis, transcriptional misregulation in cancer, and metabolic pathways, along with GO categories like protein binding, cell cycle, and ATP binding, indirectly supports the activation of ISR-related processes.